| 000 | 01327 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513091312.0 | ||
| 264 | 0 | _c19960722 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/(SICI)1097-0142(19960501)77:9<1956::AID-CNCR29>3.0.CO;2-Y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorris, D L | |
| 245 | 0 | 0 |
_aA phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. _h[electronic resource] |
| 260 |
_bCancer _cMay 1996 |
||
| 300 |
_a1956-7 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 |
_aRectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSomatostatin _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 773 | 0 |
_tCancer _gvol. 77 _gno. 9 _gp. 1956-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0142(19960501)77:9<1956::AID-CNCR29>3.0.CO;2-Y _zAvailable from publisher's website |
| 999 |
_c8645734 _d8645734 |
||